SCHEMBL714362

SCHEMBL714362

Cn1c(-c2[c]cccc2)nc2ccccc21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.54
KDM4E B2RXH2 10/20 0.54
RAB9A P51151 7/20 0.54
NPC1 O15118 6/20 0.54
SMN1; SMN2 Q16637 6/20 0.54
PKM P14618 6/20 0.54
HPGD P15428 6/20 0.54
MAPT P10636 5/20 0.54
LMNA P02545 2/20 0.54
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
TP53 P04637 5/20 0.51
GAA P10253 4/20 0.51
HSD17B10 Q99714 4/20 0.51
ALOX15 P16050 2/20 0.51
USP2 O75604 1/20 0.51
TSHR P16473 1/20 0.51
CYP3A4 P08684 2/20 0.49
MAPK1 P28482 1/20 0.49
HTT P42858 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1171430 0.80 MEN1 (0.69) ALDH1A1KDM4ERAB9ANPC1SMN1; SMN2
SCHEMBL715532 0.80 ALDH1A1 (0.57) ALDH1A1KDM4ERAB9ANPC1SMN1; SMN2
SCHEMBL713811 0.78 MAPK1 (0.54) ALDH1A1RAB9AMAPTMEN1KMT2A
SCHEMBL714363 0.75 MEN1 (0.68) ALDH1A1KDM4ERAB9ANPC1SMN1; SMN2
SCHEMBL20982597 0.74 ALDH1A1 (0.83) ALDH1A1KDM4ERAB9ANPC1SMN1; SMN2
SCHEMBL755892 0.74 TP53 (0.52) ALDH1A1KDM4ERAB9ANPC1SMN1; SMN2
SCHEMBL3140425 0.74 ALDH1A1 (0.84) ALDH1A1KDM4ERAB9ANPC1SMN1; SMN2
SCHEMBL13311159 0.73 MEN1 (0.71) ALDH1A1KDM4ERAB9ANPC1SMN1; SMN2
SCHEMBL517706 0.73 MEN1 (0.77) ALDH1A1KDM4ERAB9ANPC1SMN1; SMN2
SCHEMBL15315659 0.73 MEN1 (0.61) ALDH1A1KDM4ERAB9ANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8771843-B2 Fluorene derivative, organic compound, and light-emitting element, light-emitting device, and electronic device using the compound SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-07-08 US disclosed
US-20120049768-A1 Fluorene Derivative, Organic Compound, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Compound SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-03-01 US disclosed
US-4065427-A Polychromophoric heterocyclic ultraviolet stabilizers and their use in organic compositions EASTMAN KODAK COMPANY (US) 1977-12-27 US disclosed
US-3981822-A HETEROCYCLIC COMPOUNDS EASTMAN KODAK COMPANY (US) 1976-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120049768-A1 Fluorene Derivative, Organic Compound, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Compound AFF2, MAPRE2, AFF4 ALDH1A1 1391/4885KDM4E 2863/4885RAB9A 440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.